1. 492PG681A & G636A variants (alleles *2 & *3) of CYP2C19 gene: Susceptibility to oral cancer and chemotherapeutic outcomes. (19th December 2015) Authors: Yadav, S.S.; Parmar, D.; Chauhan, V. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 9 Page Start: ix150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Clinical Trial To Evaluate The Safety And Efficacy Of Saroglitazar Compared To Fenofibrate In Patients With Dyslipidemia. (August 2019) Authors: Parmar, D.; Krishnappa, M.; Arifahmed, F.; Mali, N.; Patel, J.; Shah, M.; Parmar, K.; Shah, C.; Faldu, K. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Preliminary Evaluation of Plasma B-Type Natriuretic Peptide as a Screening Test for Left Ventricular Diastolic Dysfunction in Non-Cardiac Intensive Care. Issue 5 (September 2013) Authors: Sturgess, D. J.; Parmar, D.; Dulhunty, J. M.; Hegde, R.; Jarrett, P.; Udy, A. Journal: Anaesthesia and intensive care Issue: Volume 41:Issue 5(2013) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of saroglitazar 4 mg compared to fenofibrate 160 mg in latino adults with moderate to severe hypertriglyceridemia-a randomized clinical trial. (August 2022) Authors: Parmar, D.; Rodriguez-Gutierrez, R.; González-González, J.G.; Shaikh, F.; Cruz-López, J.L.P. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Neuroprotective potentials of neurotrophin rich olfactory ensheathing cell's conditioned media against 6OHDA-induced oxidative damage. (May 2014) Authors: Shukla, A.; Mohapatra, T. M.; Parmar, D.; Seth, K. Journal: Free radical research Issue: Volume 48:Number 5(2014:May) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Outcomes of repeat two-stage exchange hip arthroplasty for prosthetic joint infection. (June 2019) Authors: Khan, N.; Parmar, D.; Ibrahim, M. S.; Kayani, B.; Haddad, F. S. Journal: Bone & joint journal Issue: Volume 101B:Number 6(2019)Supplement B Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Progress in the realization of the PRIMA neutral beam test facility. (21st July 2015) Authors: Toigo, V.; Boilson, D.; Bonicelli, T.; Piovan, R.; Hanada, M.; Chakraborty, A.; Agarici, G.; Antoni, V.; Baruah, U.; Bigi, M.; Chitarin, G.; Dal Bello, S.; Decamps, H.; Graceffa, J.; Kashiwagi, M.; Hemsworth, R.; Luchetta, A.; Marcuzzi, D.; Masiello, A.; Paolucci, F. Journal: Nuclear fusion Issue: Volume 55:Number 8(2015:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Saroglitazar magnesium improves lipid parameters in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis. (December 2020) Authors: Parmar, D.; Gawrieh, S.; Cusi, K.; Chalasani, N.; Cisneros Garza, L. Esthela; Bihari, C.; Cruz Lopez, J.L. Pio; Bainbridge, J.; Vellanki, R.; Shaikh, F.; Jain, P.; Maroo, S.; Manjunath, K.; Parmar, K.; Patil, K. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Saroglitazar Reduces Predictor Lipid Biomarkers Of Cardiovascular Diseases. (August 2019) Authors: Krishnappa, M.; Shah, M.; Parmar, K.; Joshi, S.; Maroo, S.; Parmar, D. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗